Titan Pharmaceuticals Stock Price - TTNP

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 0.33 ▼ -0.00 (-0.33%)
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.084 33.6% 0.334 0.383 0.28 0.28 0.25 00:00:03
Bid Price Ask Price Spread Spread % News
0.32 0.34 0.02 5.88% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
82,446 96,799,232 $ 0.327899 $ 31,740,371 15,746,360 0.14 - 2.58
Last Trade Time Type Quantity Stock Price Currency
19:59:58 formt 1,000 $ 0.3329 USD

Titan Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 19.33M 57.88M $ -9.02M -1.67 - 54.89M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Titan Pharmaceuticals News

Loading Messages....

Latest TTNP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TTNP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.310.39980.23930.268041116,492,8210.0247.74%
1 Month0.16050.39980.150.260341316,664,8770.1735108.1%
3 Months0.190.39980.140.2275658,778,2710.14475.79%
6 Months1.,452,594-0.846-71.69%
1 Year1.2872.580.140.42006813,261,058-0.953-74.05%
3 Years26.1026.700.141.532,032,450-25.77-98.72%
5 Years2.87760.000.143.071,336,131-2.54-88.39%

Titan Pharmaceuticals Description

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development of pharmaceutical products. Its product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.

Your Recent History
Titan Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.